BioAge Labs Inc.
BIOA | NASDAQ
$8.46
+$0.37 (+4.57%)
Sep 22, 2026, 2:19 PM ET · Market open
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 |
|---|---|---|---|---|
Cash & Equivalents | 188.89M | 354.35M | 21.64M | 27.64M |
Short-Term Investments | 92.21M | n/a | n/a | n/a |
Long-Term Investments | 100K | 100K | 100K | n/a |
Other Long-Term Assets | 4.25M | 240K | n/a | 25K |
Receivables | 769K | n/a | n/a | n/a |
Inventory | n/a | n/a | n/a | n/a |
Other Current Assets | 4.93M | 2.75M | 3.66M | 386K |
Total Current Assets | 286.79M | 357.1M | 25.31M | 28.03M |
Property-Plant & Equipment | 3.75M | 791K | 518K | 374K |
Goodwill & Intangibles | n/a | n/a | n/a | n/a |
Total Long-Term Assets | 8.1M | 1.13M | 618K | 399K |
Total Assets | 294.89M | 358.23M | 25.92M | 28.43M |
Account Payables | 2.67M | 2M | 1.87M | 2.26M |
Deferred Revenue | 5.75M | 7.83M | 3.31M | n/a |
Short-Term Debt | 2.65M | 6M | 44.86M | 167K |
Other Current Liabilities | 525K | 417K | 1.39M | 24K |
Total Current Liabilities | 20.14M | 27.78M | 58.17M | 5.86M |
Long-Term Debt | 2.33M | 2.5M | 8.2M | 2.25M |
Other Long-Term Liabilities | 370K | 156K | 132.95M | 132.88M |
Total Long-Term Liabilities | 2.7M | 7.33M | 141.15M | 135.13M |
Total Liabilities | 22.84M | 35.11M | 199.32M | 140.99M |
Total Debt | 5.56M | 8.7M | 53.25M | 2.47M |
Book Value | 272.05M | 323.13M | -173.4M | -112.56M |
Book Value Per Share | 7.57 | 9.01 | -5.07 | -3.29 |
Common Stock | n/a | n/a | n/a | n/a |
Retained Earnings | -333.42M | -252.81M | -181.7M | -117.85M |
Comprehensive Income | 278K | 245K | 164K | 167K |
Shareholders Equity | 272.05M | 323.13M | -173.4M | -112.56M |
Total Investments | 92.31M | 100K | 100K | n/a |
Add to Watchlist
Select watchlists to add or remove BIOA